BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37067993)

  • 21. Genome-wide Kdm4 histone demethylase transcriptional regulation in Drosophila.
    Tsurumi A; Xue S; Zhang L; Li J; Li WX
    Mol Genet Genomics; 2019 Oct; 294(5):1107-1121. PubMed ID: 31020413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting epigenetic regulators to overcome drug resistance in cancers.
    Wang N; Ma T; Yu B
    Signal Transduct Target Ther; 2023 Feb; 8(1):69. PubMed ID: 36797239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays.
    Le Bihan YV; Lanigan RM; Atrash B; McLaughlin MG; Velupillai S; Malcolm AG; England KS; Ruda GF; Mok NY; Tumber A; Tomlin K; Saville H; Shehu E; McAndrew C; Carmichael L; Bennett JM; Jeganathan F; Eve P; Donovan A; Hayes A; Wood F; Raynaud FI; Fedorov O; Brennan PE; Burke R; van Montfort RLM; Rossanese OW; Blagg J; Bavetsias V
    Eur J Med Chem; 2019 Sep; 177():316-337. PubMed ID: 31158747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heme promotes transcriptional and demethylase activities of Gis1, a member of the histone demethylase JMJD2/KDM4 family.
    Lal S; Comer JM; Konduri PC; Shah A; Wang T; Lewis A; Shoffner G; Guo F; Zhang L
    Nucleic Acids Res; 2018 Jan; 46(1):215-228. PubMed ID: 29126261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.
    Horton JR; Engstrom A; Zoeller EL; Liu X; Shanks JR; Zhang X; Johns MA; Vertino PM; Fu H; Cheng X
    J Biol Chem; 2016 Feb; 291(6):2631-46. PubMed ID: 26645689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of JmjC-domain-containing histone demethylase (KDM2-7) inhibitors for cancer therapy.
    Zhang L; Chen Y; Li Z; Lin C; Zhang T; Wang G
    Drug Discov Today; 2023 May; 28(5):103519. PubMed ID: 36754142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.
    Rotili D; Tomassi S; Conte M; Benedetti R; Tortorici M; Ciossani G; Valente S; Marrocco B; Labella D; Novellino E; Mattevi A; Altucci L; Tumber A; Yapp C; King ON; Hopkinson RJ; Kawamura A; Schofield CJ; Mai A
    J Med Chem; 2014 Jan; 57(1):42-55. PubMed ID: 24325601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzo[
    Kim YJ; Lee DH; Choi YS; Jeong JH; Kwon SH
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reader domain specificity and lysine demethylase-4 family function.
    Su Z; Wang F; Lee JH; Stephens KE; Papazyan R; Voronina E; Krautkramer KA; Raman A; Thorpe JJ; Boersma MD; Kuznetsov VI; Miller MD; Taverna SD; Phillips GN; Denu JM
    Nat Commun; 2016 Nov; 7():13387. PubMed ID: 27841353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer.
    Liu JS; Fang WK; Yang SM; Wu MC; Chen TJ; Chen CM; Lin TY; Liu KL; Wu CM; Chen YC; Chuu CP; Wang LY; Hsieh HP; Kung HJ; Wang WC
    J Biomed Sci; 2022 May; 29(1):29. PubMed ID: 35534851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase.
    Ipenberg I; Guttmann-Raviv N; Khoury HP; Kupershmit I; Ayoub N
    J Biol Chem; 2013 May; 288(21):14681-7. PubMed ID: 23589305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of histone demethylase KDM4 by ML324 induces apoptosis through the unfolded protein response and Bim upregulation in hepatocellular carcinoma cells.
    Kim SY; Hwang S; Lee BR; Hong JA; Sung YH; Kim I
    Chem Biol Interact; 2022 Feb; 353():109806. PubMed ID: 34999051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone demethylase JMJD2B/KDM4B regulates transcriptional program via distinctive epigenetic targets and protein interactors for the maintenance of trophoblast stem cells.
    Mak KH; Lam YM; Ng RK
    Sci Rep; 2021 Jan; 11(1):884. PubMed ID: 33441614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone lysine demethylases in Drosophila melanogaster.
    Holowatyj A; Yang ZQ; Pile LA
    Fly (Austin); 2015; 9(1):36-44. PubMed ID: 26207949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SCF(FBXO22) regulates histone H3 lysine 9 and 36 methylation levels by targeting histone demethylase KDM4A for ubiquitin-mediated proteasomal degradation.
    Tan MK; Lim HJ; Harper JW
    Mol Cell Biol; 2011 Sep; 31(18):3687-99. PubMed ID: 21768309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KDM4 Involvement in Breast Cancer and Possible Therapeutic Approaches.
    Varghese B; Del Gaudio N; Cobellis G; Altucci L; Nebbioso A
    Front Oncol; 2021; 11():750315. PubMed ID: 34778065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors.
    King ON; Li XS; Sakurai M; Kawamura A; Rose NR; Ng SS; Quinn AM; Rai G; Mott BT; Beswick P; Klose RJ; Oppermann U; Jadhav A; Heightman TD; Maloney DJ; Schofield CJ; Simeonov A
    PLoS One; 2010 Nov; 5(11):e15535. PubMed ID: 21124847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SUMO Modification of Histone Demethylase KDM4A in Kaposi's Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
    Yeh WW; Chen YQ; Yang WS; Hong YC; Kao S; Liu TT; Chen TW; Chang L; Chang PC
    J Virol; 2022 Aug; 96(16):e0075522. PubMed ID: 35914074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KDM4 Inhibition Targets Breast Cancer Stem-like Cells.
    Metzger E; Stepputtis SS; Strietz J; Preca BT; Urban S; Willmann D; Allen A; Zenk F; Iovino N; Bronsert P; Proske A; Follo M; Boerries M; Stickeler E; Xu J; Wallace MB; Stafford JA; Kanouni T; Maurer J; Schüle R
    Cancer Res; 2017 Nov; 77(21):5900-5912. PubMed ID: 28883001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.
    Westaway SM; Preston AG; Barker MD; Brown F; Brown JA; Campbell M; Chung CW; Diallo H; Douault C; Drewes G; Eagle R; Gordon L; Haslam C; Hayhow TG; Humphreys PG; Joberty G; Katso R; Kruidenier L; Leveridge M; Liddle J; Mosley J; Muelbaier M; Randle R; Rioja I; Rueger A; Seal GA; Sheppard RJ; Singh O; Taylor J; Thomas P; Thomson D; Wilson DM; Lee K; Prinjha RK
    J Med Chem; 2016 Feb; 59(4):1357-69. PubMed ID: 26771107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.